TP53 abnormalities are underlying the poor outcome associated with chromothripsis in chronic lymphocytic leukemia patients with complex karyotype

Ramos-Campoy, S. (Silvia); Puiggros, A. (Anna); Kamaso, J. (Joanna); Bea, S. (Silvia); Bougeon, S. (Sandrine); Larrayoz, M.J. (María J.); Costa, D. (Dolors); Parker, H. (Helen); Rigolin, G.M. (Gian Matteo); Blanco, M.L. (María Laura); Collado, R. (Rosa); Ancín, I. (Idoya); Salgado, R. (Rocío); Moro-García, M.A. (Marco A.); Baumann, T. (Tycho); Gimeno, E. (Eva); Moreno, C. (Carolina); Salido, M. (Marta); Calvo, X. (Xavier); Calasanz-Abinzano, M.J. (Maria Jose); Cuneo, A. (Antonio); Nguyen-Khac, F. (Florence); Oscier, D. (David); Haferlach, C. (Claudia); Strefford, J.C. (Jonathan C.); Schoumans, J. (Jacqueline); Espinet, B. (Blanca)

Keywords:

Chronic lymphocytic leukemia
Genomic complexity
Chromothripsis
TP53
Genomic microarrays
Optical genome mapping

Issue Date:

2022

Publisher Version:

https://pubmed.ncbi.nlm.nih.gov/35954380/

ISSN:

2072-6694

Note:

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) licens

Citation:

Ramos-Campoy, S.; Puiggros, A.; Kamaso, J.; et al. "TP53 abnormalities are underlying the poor outcome associated with chromothripsis in chronic lymphocytic leukemia patients with complex karyotype". Cancers. 14 (15), 2022, 3715

Abstract

Simple Summary Chromothripsis, a genomic event that generates massive chromosomal rearrangements, has been described in 1-3% of CLL patients and is associated with poor prognostic factors (e.g., TP53 abnormalities and genomic complexity). However, previous studies have not assessed its role in CLL patients with complex karyotypes. Herein, we aimed to describe the genetic characteristics of 33 CLL patients with high genomic complexity and chromothripsis. Moreover, we analyzed the clinical impact of chromothripsis, comparing these patients against a cohort of 129 patients with complex karyotypes not presenting this catastrophic event. Nine cases were also assessed via the novel cytogenomic methodology known as optical genome mapping. We confirmed that this phenomenon is heterogeneous and associated with a shorter time to first treatment. Nonetheless, our findings suggested that TP53 abnormalities, rather than chromothripsis itself, underlie the dismal outcome. Chromothripsis (cth) has been associated with a dismal outcome and poor prognosis factors in patients with chronic lymphocytic leukemia (CLL). Despite being correlated with high genome instability, previous studies have not assessed the role of cth in the context of genomic complexity. Herein, we analyzed a cohort of 33 CLL patients with cth and compared them against a cohort of 129 non-cth cases with complex karyotypes. Nine cth cases were analyzed using optical genome mapping (OGM). Patterns detected by genomic ...

URI:

https://hdl.handle.net/10171/64147

DOI:

10.3390/cancers14153715

Appears in Collections:

DA - Ciencias - Bioquímica y Genética - Artículos de revista

Files in This Item: